Avalyn Announces Pricing of Upsized Initial Public Offering
Summary
BOSTON, April 29, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) ('Avalyn”), a clinical-stage biopharmaceutical company pioneering inhaled therapi...
Description
BOSTON, April 29, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) ('Avalyn”), a clinical-stage biopharmaceutical company pioneering inhaled therapi...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source